Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. CDC Says Administered 413,645,478 Doses Of Covid-19 Vaccine As Of Oct 24

10/24/2021 | 03:14pm EST

Oct 24 (Reuters) - U.S. CDC:

* U.S. CDC SAYS ADMINISTERED 413,645,478 DOSES OF COVID-19 VACCINE AS OF OCT 24 VERSUS 412,856,169 DOSES ADMINISTERED AS OF OCT 23

* U.S. CDC SAYS 220,351,217 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF OCT 24 VERSUS 220,145,796 INDIVIDUALS AS OF OCT 23

* U.S. CDC SAYS 190,578,704 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF OCT 24 VERSUS 190,402,262 INDIVIDUALS AS OF OCT 23

* U.S. CDC SAYS AS OF OCTOBER 24, 12,888,226 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021 Further company coverage:


ę Reuters 2021
All news about MODERNA, INC.
04:48aStocks roar higher as traders park COVID and Fed jitters
RE
04:06aModerna CEO Says Vaccines Likely Less Effective Against Omicron
AQ
03:55aCOVID comeback caps a November to remember in markets
RE
01:21aGlobal markets dip as Moderna chief sounds alarm on Omicron
AQ
01:07aOmicron Variant Was in Western Europe Days Before First Identified in Southern Africa
AQ
12:48aAsian shares bounce sharply from year low but Omicron, Fed in focus
RE
11/30WRAPUP 4-U.S. tightens travel rules as more countries secure borders to quell Omicron
RE
11/30CORRECTION : Moderna CEO Says Booster Shots For Omicron Could Need Double Dosage
MT
11/30Copper rebounds as concerns over Omicron virus variant ease
RE
11/30Wheat firms, supply outlook and COVID-19 fears cap gains
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 449 M - -
Net income 2021 11 169 M - -
Net cash 2021 12 344 M - -
P/E ratio 2021 13,4x
Yield 2021 -
Capitalization 143 B 143 B -
EV / Sales 2021 7,48x
EV / Sales 2022 5,84x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 352,43 $
Average target price 272,53 $
Spread / Average Target -22,7%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.237.35%142 893
LONZA GROUP AG30.63%59 859
IQVIA HOLDINGS INC.44.63%49 504
SEAGEN INC.-8.64%29 257
CELLTRION, INC.-42.34%23 827
ICON PUBLIC LIMITED COMPANY38.72%22 016